Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response-Reference-Cited by-同舟云学术

Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response

Published:2020-09-09 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Yahouédéhou Sètondji Cocou Modeste Alexandre,Neres Joelma Santana dos Santos,da Guarda Caroline Conceição,Carvalho Suellen Pinheiro,Santiago Rayra Pereira,Figueiredo Camylla Vilas Boas,Fiuza Luciana Magalhães,Ndidi Uche Samuel,de Oliveira Rodrigo Mota,Fonseca Cleverson Alves,Nascimento Valma Maria Lopes,Rocha Larissa Carneiro,Adanho Corynne Stéphanie Ahouéfa,da Rocha Tiago Santos Carvalho,Adorno Elisângela Vitória,Goncalves Marilda Souza

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference54 articles.

1. Genetic predisposition to molecular response in patients with myeloproliferative neoplasms treated with hydroxycarbamide;Angona;Leuk. Res.,2013

2. Frecuencia del polimorfismo -262 C/T en el gen de la catalasa y lesión oxidativa en niños eslovacos con asma bronquial;Babusikova;Archiv. Bronconeumol.,2013

3. Hidroxiuréia em pacientes com síndromes falciformes acompanhados no Hospital Hemope, Recife, Brasil;Bandeira;Rev. Bras. Hematol. Hemoter.,2004

4. Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use;Belini Junior;Blood Cells Mol. Dis.,2015

5. CYP3A4 and CYP3A5 Polymorphisms and Blood Pressure Response to Amlodipine among African-American Men and Women with Early Hypertensive Renal Disease;Bhatnagar;Am. J. Nephrol.,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Down-regulation of SLC14A1 in prostate cancer activates CDK1/CCNB1 and mTOR pathways and promotes tumor progression;Scientific Reports;2024-06-28

2. Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children;International Journal of Molecular Sciences;2023-05-15

3. Opportunity for pharmacogenetics testing in patients with sickle cell anemia;Pharmacogenomics;2022-11

4. Identification of hub genes and key pathways in pediatric Crohn’s disease using next generation sequencing and bioinformatics analysis;2022-07-28

5. Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease;Pharmaceutics;2022-05-16